Digital Marketing · Service
Marketing for speciality clinics in the UAE
Patient acquisition inside the rules that actually bind.
At a glance
What it is
“Most clinic campaigns are not rejected for bad creative. They are rejected for a superlative nobody flagged.”
A principal, Kaelo Digital Marketing
What’s included
Four areas of scopeThe economics the clinic is actually managing
Patient acquisition cost by speciality, appointment-to-show and no-show rate, chair or room utilisation, payer mix and the self-pay share. A campaign that raises enquiries while utilisation is already at capacity has cost the clinic money.
Creative built to clear review
No guarantees, no superlatives, licence numbers where they belong, consented before-and-after with the disclaimers intact, and generic rather than brand drug naming. Built to pass at the first submission rather than reworked after rejection.
Channel selection under category restriction
Google and Meta both restrict health categories, and certification requirements vary by market. Where the walled gardens will not carry a category, budget has to move — usually to owned search, endemic programmatic and the alternative platforms.
Retention, not just acquisition
Recall, reactivation and the referral pathway. Most clinic marketing is priced on new patients when the economics are decided by the second and third visit.
How the work runs
Utilisation and economics review
Where capacity actually sits, and what a marginal patient is worth by speciality. This decides whether the brief is acquisition or something else entirely.
Approval-path mapping
Which authority governs the facility, which gates apply to the campaign, and what has to be cleared before a single ad is built. Confirmed with your compliance lead, not assumed.
Build, submit, run
Creative and landing pages produced to the review standard, submitted, and launched once cleared.
Reported on the clinical calendar
Enquiries, show rate and utilisation — not impressions.
When to come to us
- 01 You are a licensed facility and can put your compliance lead in the approval path.
- 02 You have capacity you want filled, or a speciality you want to grow.
- 03 You would rather clear review once than rebuild a campaign twice.
What we do not do
- Medical or clinical content of any kind — we market, we do not advise on treatment.
- Claims about outcomes, success rates or comparative efficacy.
- Before-and-after material without documented patient consent.
- Submitting anything to a regulator that your own compliance lead has not approved.
The legal layer is written for compliance officers.
Law firms and the regulators cover what the rules say, rigorously, and stop there. Almost nobody covers what a marketer is supposed to do about them — the sequence, the platform-by-platform position, the order of operations.
Related reading
The order of operations, and where campaigns actually fail. →
Patient acquisition cost, show rate and utilisation — the three that decide it. →
High treatment value, restricted channels, and a compliance surface most agencies never see. →
Chair utilisation is the constraint. Almost nothing else is. →
Common questions
